Table 2.

Intraepithelial and stromal lymphocyte subsets and their prediction for DSS in NSCLC patients (univariate analysis; log-rank test)

Marker expressionPatients, n (%)Mean survival (mo)5-y survival (%)P
CD4
    Tumor
        Low252 (75)107560.46
        High78 (24)11360
        Missing3 (1)
    Stroma
        Low82 (25)7042<0.001
        High251 (74.5)12163
        Missing2 (0.5)
CD8
    Tumor
        Low243 (42)102540.023
        High85 (58)12568
    Stroma
        Low268 (80)99530.002
        High61 (18)14375
        Missing6 (2)
CD20
    Tumor
        Low263 (78.5)104550.023
        High68 (20.5)11567
        Missing4 (1)
    Stroma
        Low42 (16.5)5632<0.001
        High292 (83)11561
        Missing1 (0.5)